Cell separation compositions and methods

Chemistry: molecular biology and microbiology – Animal cell – per se ; composition thereof; process of... – Primate cell – per se

Reexamination Certificate

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C435S002000, C435S007230, C435S007240, C435S007250, C435S355000, C435S372100, C435S372200, C435S372300, C436S523000, C436S529000, C436S010000, C436S017000, C436S063000, C436S064000, C424S093710

Reexamination Certificate

active

10094456

ABSTRACT:
The invention provides compositions and methods for cell separation. These reagents and techniques specifically agglutinate cells via surface antigen recognition and can be used to recover even rare cell types in high yield.

REFERENCES:
patent: 4946778 (1990-08-01), Ladner et al.
patent: 5773224 (1998-06-01), Grandics et al.
patent: 5840502 (1998-11-01), Van Vlasselaer
patent: 5877299 (1999-03-01), Thomas et al.
patent: 6117985 (2000-09-01), Thomas et al.
patent: 6146628 (2000-11-01), Uckun et al.
patent: 6153113 (2000-11-01), Goodrich et al.
patent: 6280622 (2001-08-01), Goodrich et al.
patent: 6491917 (2002-12-01), Thomas et al.
patent: 6544751 (2003-04-01), Brandwein et al.
patent: 6933148 (2005-08-01), Collins et al.
patent: 0 670 185 (1995-09-01), None
patent: 0 844 482 (1998-05-01), None
patent: 10-059854 (1998-03-01), None
Cruse et al., Illustrated Dictionary of Immunology, CRC Press Inc 1995, pp. 157-159.
Vettese-Dadey, “Going Their Separate Ways: A Profile of Products for Cell Separation,”The Scientist, 1999, vol. 13, No. 18, 10 pgs.
Bigbee et al., “Monoclonal Antibodies Specific for the M- and N-Forms of Human Glycoprotein A,”Mol. Immunol., 1983, 20(12):1353-1362.
Cole et al., “The EBV-Hybridoma Technique and its Application to Human Lung Cancer,”Monoclonal Antibodies and Cancer Therapy, 1985, Alan R. Liss, Inc., New York, pp. 77-96.
Cote et al., “Generation of human monoclonal antibodies reactive with cellular antigens,”Proc. Natl. Acad. Sci. USA, 1983, 80:2026-2030.
Collins, “Cytokine and cytokine receptor expression as a biological indicator of immune activation: important considerations in the development of in vitro model systems,”J. Immunol. Meth., 2000, 243:125-145.
Eggens et al., “Specific Interaction between Lexand LexDeterminants,”J. Biol. Chem., 1989, 264(16):9476-9484.
Huse et al., “Generation of a Large Combinatorial Library of the Immunoglobulin Repertoire in Phage Lambda,”Science, 1989, 246:1275-1281.
Jennings et al., “CD9 cluster workshop report: cell surface binding and functional analysis,”Leucocyte Typing V, 1995, Oxford University Press, Oxford, pp. 1249-1251.
Kannagi et al., “A Series of Human Erythrocyte Glycosphingolipids Reacting to the Monoclonal Antibody Directed to a Developmentally Regulated Antigen, SSEA-1,”J. Biol. Chem., 1982, 257(2):14865-14872.
Kishimoto (chairman), 6thInternational Workshop and Conference on Human Leukocyte Differentiation Antigens, Nov. 10-14, 1996, Kobe, Japan (Table of Contents only).
Knapp et al., (eds.),Leucocyte Typing IV, 1989, Oxford University Press, Oxford (Table of Contents only).
Kohler and Milstein, “Continuous cultures of fused cells secreting antibody of predefined specificity,”Nature, 1975, 256(5512):495-497.
Kozbor and Roder, “The production of monoclonal antibodies from human lymphocytes,”Immunology Today, 1983, 4(3):72-79.
Lanza et al., “cDNA Cloning and Expression of Platelet p24/CD9,”J. Biol. Chem., 1991, 266(16):10638-10645.
Magnani et al., “Monoclonal Antibodies PMN 6, PMN 29, and PM-81 Bind Differently to Glycolipids Containing a Sugar Sequence Occurring in Lacto-N-Fucopentaose III,”Arch. Biochem. Biophys., 1984, 233(2):501-506.
Outram et al., “Erythromyeloid Lineage Fidelity is Conserved in Erythroleukaemia,”Leukemia Research, 1988, 12(8):651-657.
Reinherz et al., (eds.),Leukocyte Typing II, 1986, Springer-Verlag, New York (Table of Contents only).
Rubinstein et al., “Anti-Platelet Antibody Interactions wtih Fcγ Receptor,”Seminars in Thrombosis and Hemostasis, 1995, 21:10-22.
Solter and Knowles, “Monoclonal antibody defining a stage-specific mouse embryonic antigen (SSEA-1),”Proc. Natl. Acad. Sci. USA, 1978, 75(11):5565-5569.
Telen and Bolk, “Human red cell antigens,”Transfusion, 1987, 27:309-314.
Von dem Borne and Modderman, “Cluster Report: CD9,”Leucocyte Typing IV, 1989, Oxford University Press, Oxford, pp. 989-992.
Wagner, “Umbilical Cord Blood Stem Cell Transplantation,”Am. J. Ped. Hematol./Oncol., 1993, 15(2):169-174.
Wright and Tomlinson, “The ins and outs of the transmembrane 4 superfamily,”Immunol. Today, 1994, 15(12):588-594.

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Cell separation compositions and methods does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Cell separation compositions and methods, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Cell separation compositions and methods will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-3743305

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.